SK
Surendra Kumar Dubey
About Surendra Kumar Dubey
Data last updated:
Surendra Kumar Dubey is a Director at Cutem Pharma Private Limited (since 2023). The companies operate in Chemicals. Cutem Pharma Private Limited reported revenue of ₹36.1 Lakh (FY 2025). Earlier, Surendra Kumar Dubey was a Director at Cutemheal Pharma Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Jan 2023 | 2023 | ₹36.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Jan 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Surendra Kumar Dubey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Birendra Harinarayan Pandey | 09856173 | Cutem Pharma Private Limited | Director |
| Priya Mishra | 11214196 | Cutem Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surendra Kumar Dubey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surendra Kumar Dubey
Surendra Kumar Dubey currently holds 1 directorship: Cutem Pharma Private Limited (Director, since 10 Jan 2023, revenue ₹36.1 Lakh (FY 2025)).
Surendra Kumar Dubey was first appointed on 08 Jan 2021 as Director at Cutemheal Pharma Private Limited. The most recent appointment on record is 10 Jan 2023 at Cutem Pharma Private Limited.
Surendra Kumar Dubey held 1 earlier board appointment: Cutemheal Pharma Private Limited (Director, from 08 Jan 2021).
The current boards of Surendra Kumar Dubey's companies include Birendra Harinarayan Pandey (Cutem Pharma Private Limited), Priya Mishra (Cutem Pharma Private Limited).